Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L B Goldstein

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Stroke|September 6, 2001
Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteriaL B Goldstein, M R Jones, D B Matchar, et al.
Neurology|September 5, 2008
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attackS Chaturvedi, J Zivin, A Breazna, et al.
Journal of Toxicology and Environmental Health. Part A|April 6, 2001
Effects of daily dermal application of DEET and epermethrin, alone and in combination, on sensorimotor performance, blood-brain barrier, and blood-testis barrier in ratsM B Abou-Donia, L B Goldstein, A Dechovskaia, et al.
Stroke|September 2, 1999
Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare professionals from the Stroke Council of the American Heart AssociationP A Wolf, G P Clagett, J D Easton, et al.
Stroke|May 1, 1997
Knowledge of risk among patients at increased risk for strokeG P Samsa, S J Cohen, L B Goldstein, et al.
Neurology|February 1, 1989
A dose escalation study of ORG 10172 (low molecular weight heparinoid) in strokeJ Biller, E W Massey, J R Marler, et al.
Stroke|September 1, 1995
US national survey of physician practices for the secondary and tertiary prevention of ischemic stroke. Design, service availability, and common practicesL B Goldstein, A J Bonito, D B Matchar, et al.
Health Services Research|August 1, 1997
Influence of projected complication rates on estimated appropriate use rates for carotid endarterectomy. Appropriateness Project Investigators. Academic Medical Center ConsortiumD B Matchar, E Z Oddone, D C McCrory, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 15, 2001
Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin, alone and in combinationM B Abou-Donia, L B Goldstein, K H Jones, et al.
Neurology|July 10, 2002
Anticoagulants and antiplatelet agents in acute ischemic stroke [RETIRED]: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association)B M Coull, L S Williams, L B Goldstein, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Stroke|September 6, 2001
Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteriaL B Goldstein, M R Jones, D B Matchar, et al.
Neurology|September 5, 2008
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attackS Chaturvedi, J Zivin, A Breazna, et al.
Journal of Toxicology and Environmental Health. Part A|April 6, 2001
Effects of daily dermal application of DEET and epermethrin, alone and in combination, on sensorimotor performance, blood-brain barrier, and blood-testis barrier in ratsM B Abou-Donia, L B Goldstein, A Dechovskaia, et al.
Stroke|September 2, 1999
Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare professionals from the Stroke Council of the American Heart AssociationP A Wolf, G P Clagett, J D Easton, et al.
Stroke|May 1, 1997
Knowledge of risk among patients at increased risk for strokeG P Samsa, S J Cohen, L B Goldstein, et al.
Neurology|February 1, 1989
A dose escalation study of ORG 10172 (low molecular weight heparinoid) in strokeJ Biller, E W Massey, J R Marler, et al.
Stroke|September 1, 1995
US national survey of physician practices for the secondary and tertiary prevention of ischemic stroke. Design, service availability, and common practicesL B Goldstein, A J Bonito, D B Matchar, et al.
Health Services Research|August 1, 1997
Influence of projected complication rates on estimated appropriate use rates for carotid endarterectomy. Appropriateness Project Investigators. Academic Medical Center ConsortiumD B Matchar, E Z Oddone, D C McCrory, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 15, 2001
Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin, alone and in combinationM B Abou-Donia, L B Goldstein, K H Jones, et al.
Neurology|July 10, 2002
Anticoagulants and antiplatelet agents in acute ischemic stroke [RETIRED]: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association)B M Coull, L S Williams, L B Goldstein, et al.
Pageof 11